Jan van der Auwera
Direktor/Vorstandsmitglied bei Travel & Communication Consultancy Bvba
Ursprung des Netzwerks ersten Grades von Jan van der Auwera
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jan van der Auwera
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SOLVAY SA | Chemicals: Specialty | Corporate Officer/Principal | |
| GALAPAGOS NV | Biotechnology | Chief Tech/Sci/R&D Officer Public Communications Contact | |
| University of Bradford | College/University | Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Investor Relations Contact | |
Docpharma NV
 Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Pharmaceuticals: Major | Director of Finance/CFO | |
| HAMON & CIE (INTERNATIONAL) S.A. | Industrial Machinery | Treasurer | |
Vlaamse Instelling voor Technologisch Onderzoek NV
 Vlaamse Instelling voor Technologisch Onderzoek NV BiotechnologyHealth Technology Vlaamse Instelling Voor Technologisch Onderzoek NV provides customer research services. The company provides its services to the energy suppliers, appliance builders, end users and government sectors. The company was founded in 1991 and is headquartered in Mol, Belgium. | Biotechnology | Director/Board Member | |
KBC Securities USA, Inc.
 KBC Securities USA, Inc. Investment Banks/BrokersFinance Founded in 1999, KBC Securities USA, Inc. is a broker/dealer located in New York City. The firm began as the Financial Products group of D. E. Shaw & Co. In 1999, they were purchased by KBC Bank NV. They are a subsidiary of KBC Securities USA, Inc. and their ultimate parent is of KBC Groupe SA (LSE: KBC). KBC Securities is a specialist in annuities, convertible bonds and equity derivatives with a strategic focus on technology. They serve a range of global investors including mutual funds, pension funds, insurance companies, banks, private banks and hedge funds. | Investment Banks/Brokers | Chief Executive Officer | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Zeneca Garden Care
 Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| University of Tilburg | College/University | Undergraduate Degree | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Masters Business Admin | |
| Loyola University Maryland, Inc. | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member | |
| Trinity College Dublin | College/University | Graduate Degree | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| Université Libre de Bruxelles | College/University | Graduate Degree | |
| Swansea University | College/University | Doctorate Degree | |
| University of Liege | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Hasselt University | College/University | Graduate Degree | |
| Université Catholique de Louvain | College/University | Graduate Degree Graduate Degree | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member | |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SMB Technology
 SMB Technology Information Technology ServicesTechnology Services Part of Laboratoires S.M.B. SA, SMB Technology is a Belgian company that provides IT consulting services. The company is based in Brussels, Belgium. The CEO of the company is Caroline Baudier. | Information Technology Services | Chief Tech/Sci/R&D Officer | |
| SENSORION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Belgische federatie van de chemische industrie en van life
 Belgische federatie van de chemische industrie en van life Miscellaneous Commercial ServicesCommercial Services Belgische federatie van de chemische industrie en van life, also known as essenscia, is a Belgian company based in Brussels, Belgium. The company represents the interests of Belgian companies operating in the chemical, pharmaceutical, and biotech industries. Yves Verschueren has been the CEO of the private company since 2007. | Miscellaneous Commercial Services | Director/Board Member | |
| Brussels Enterprises Commerce & Industry | Director/Board Member | ||
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Equipment/Instruments | Director/Board Member Director of Research - Fxd Inc | |
Neem Biotech Ltd.
 Neem Biotech Ltd. Pharmaceuticals: MajorHealth Technology Part of InQpharm Group, Neem Biotech Ltd. is a British biotech company focused on developing groundbreaking ways of defeating big health challenges. The company is based in St. Mellons, UK. Leveraging their unique position in antimicrobial R&D, they have expertise in drug discovery. Neem Biotech was acquired by InQpharm Group on August 09, 2012. | Pharmaceuticals: Major | Chief Executive Officer | |
Novalon SA
 Novalon SA Pharmaceuticals: MajorHealth Technology Novalon SA manufactures pharmaceutical products. It focuses on the development of therapeutically equivalent generic products that are complex to develop and manufacture. The firm develops the projects Zoreline and Myring, which are therapeutic equivalents to branded products. The company is headquartered in Liege, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
Odyssea Pharma SRL
 Odyssea Pharma SRL Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Odyssea Pharma SPRL is a pharmaceutical development and Belgian production company. The company is based in Grâce-Hollogne, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
| Gepecom Bvba | Director/Board Member | ||
| Gepetrans Bvba | Chief Executive Officer | ||
| Vesteco Bvba | Director/Board Member | ||
| Noxx Antwerp Bvba | Director/Board Member | ||
| Alius Modi SPRL | Chief Executive Officer | ||
| Sunzi Sprl | Director/Board Member | ||
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Miscellaneous Commercial Services | Chairman | |
Zaluvida Holdings Pte Ltd.
 Zaluvida Holdings Pte Ltd. Other Consumer ServicesConsumer Services Zaluvida Holdings Pte Ltd. provides solutions that improve the lives of livestock and protect the planet. Zaluvida Holdings is based in Singapore, Singapore. The Singaporean company also offers products that help pets stay healthier. The private company's focus is on developing new alternatives to antibiotics that can benefit farmers. and has subsidiaries in Switzerland, Germany, and Malaysia. | Other Consumer Services | Chief Tech/Sci/R&D Officer | |
Hedera 22 SA
 Hedera 22 SA Electronics DistributorsDistribution Services Hedera 22 SCRL supplies and leases computers and office equipment. The company was founded by Sébastien Rigali, Pierre Tocquin, Marc Hanikenne and Denis Baurain on May 25, 2015 and is headquartered in Esneux, Belgium. | Electronics Distributors | Director/Board Member | |
AuXin Surgery SA
 AuXin Surgery SA Medical SpecialtiesHealth Technology AuXin Surgery SA develops, manufactures, and supplies combined medical devices for non-invasive surgery. The private company is based in Ottignies-Louvain-la-Neuve, Belgium. The Belgian company was founded in 2014 by Philippe Capart, Cecile Capart, Herve Capart, Carlo Zini, and Gilles Capart. The CEO is Benoît Verjans. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
The Shift
 The Shift Miscellaneous Commercial ServicesCommercial Services The Shift operates as an association. | Miscellaneous Commercial Services | Director/Board Member | |
Apaxen SA
 Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020. | Biotechnology | Chairman | |
| Neuralis SA | Miscellaneous Commercial Services | Chief Executive Officer |
Statistik
International
| Belgien | 31 |
| Vereinigtes Königreich | 7 |
| Vereinigte Staaten | 6 |
| Frankreich | 3 |
| Niederlande | 3 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 15 |
| Commercial Services | 5 |
| Process Industries | 2 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 15 |
| Chief Tech/Sci/R&D Officer | 14 |
| Graduate Degree | 12 |
| Chief Executive Officer | 9 |
| Corporate Officer/Principal | 6 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Jan van der Auwera
- Unternehmensverbindungen